RetinalGenix Technologies Inc. (RTGN)

USD 53.0

(88.0%)

Total Assets Summary of RetinalGenix Technologies Inc.

  • RetinalGenix Technologies Inc.'s latest annual total assets in 2023 was 156.00 USD , down -46.94% from previous year.
  • RetinalGenix Technologies Inc.'s latest quarterly total assets in 2024 Q2 was 87.01 Thousand USD , up 72.26% from previous quarter.
  • RetinalGenix Technologies Inc. reported annual total assets of 294.00 USD in 2022, down -94.06% from previous year.
  • RetinalGenix Technologies Inc. reported annual total assets of 4947.00 USD in 2021, down -91.9% from previous year.
  • RetinalGenix Technologies Inc. reported quarterly total assets of 50.51 Thousand USD for 2024 Q1, up 32282.69% from previous quarter.
  • RetinalGenix Technologies Inc. reported quarterly total assets of 2119.00 USD for 2023 Q2, down -72.48% from previous quarter.

Annual Total Assets Chart of RetinalGenix Technologies Inc. (2023 - 2018)

Historical Annual Total Assets of RetinalGenix Technologies Inc. (2023 - 2018)

Year Total Assets Total Assets Growth
2023 156.00 USD -46.94%
2022 294.00 USD -94.06%
2021 4947.00 USD -91.9%
2020 61.07 Thousand USD 12.31%
2019 54.38 Thousand USD 0.0%
2018 - USD 0.0%

Peer Total Assets Comparison of RetinalGenix Technologies Inc.

Name Total Assets Total Assets Difference
Acutus Medical, Inc. 53.96 Million USD 100.0%
Biotricity, Inc. 5.94 Million USD 99.997%
Cell MedX Corp. 46.12 Thousand USD 99.662%
Dynatronics Corporation 25.94 Million USD 99.999%
Nemaura Medical Inc. 14.56 Million USD 99.999%
PetVivo Holdings, Inc. 3.11 Million USD 99.995%
Sonendo, Inc. 78.16 Million USD 100.0%
Telesis Bio, Inc. 70.41 Million USD 100.0%
Talis Biomedical Corporation 98.34 Million USD 100.0%
Viveve Medical, Inc. 25.91 Million USD 99.999%